Trial Profile
Maternal Screening and Antiviral Therapy in Pregnant Women to Reduce Mother-to-infant Transmission of Hepatitis B Virus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Dec 2023
Price :
$35
*
At a glance
- Drugs Tenofovir alafenamide (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 14 Nov 2023 Results of long-term liver outcomes of women who received TAF during pregnancy to prevent maternal HBV transmission, presented at The Liver Meeting 2023: 74th Annual Meeting of the American Association for the Study of Liver Diseases
- 07 Nov 2022 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified November 2020).
- 10 Oct 2018 New trial record